Concepedia

Author

Liang Feng

Texas Tech University Health Sciences CenterORCID

Also Known As

Feng Liang, Liang Feng

23

Publications

516

Citations

14

H-Index

26

Concepts

All Affiliations

Texas Tech University Health Sciences CenterTexas Tech UniversityZhejiang UniversityFirst Affiliated Hospital Zhejiang UniversityNanjing Medical University
LF

About

Liang Feng is an author at Texas Tech University Health Sciences Center specializing in medicine, immunology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

80

2

Immunology

2

2

61

3

Engineering

1

1

19

4

Biomedical Engineering

1

1

19

5

Cell Biology

1

1

19

Liang Feng

×

11

Publications

348

Citations

11

H-Index

YearCitations

Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy

Jianjun Zou, Shan Su, Zhuohong Chen,

Artificial Cells Nanomedicine and Biotechnology

2019

65

A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma

Yan Li, Yongliang Chen, Ming Su,

Chinese Medical Journal

2016

55

hUC-MSC-EV-miR-24 enhances the protective effect of dexmedetomidine preconditioning against myocardial ischemia–reperfusion injury through the KEAP1/Nrf2/HO-1 signaling

Zixin Hou, Fengrui Yang, Kemin Chen,

Drug Delivery and Translational Research

2023

42

Efficacy of Anti-RON Antibody Zt/g4–Drug Maytansinoid Conjugation (Anti-RON ADC) as a Novel Therapeutics for Targeted Colorectal Cancer Therapy

Liang Feng, Hangping Yao, Wei Wang,

Clinical Cancer Research

2014

32

RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Sreedhar Reddy Suthe, Hangping Yao, Tian-Hao Weng,

Molecular Cancer Therapeutics

2018

27

Preclinical Efficacy of Anti-RON Antibody–Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase

Hangping Yao, Liang Feng, Tian-Hao Weng,

Molecular Pharmaceutics

2018

25

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

Xiang-Min Tong, Liang Feng, Sreedhar Reddy Suthe,

Journal for ImmunoTherapy of Cancer

2019

23

Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

Hangping Yao, Liang Feng, Sreedhar Reddy Suthe,

Journal for ImmunoTherapy of Cancer

2019

23

Therapeutic evaluation of monoclonal antibody-maytansinoid conjugate as a model of RON-targeted drug delivery for pancreatic cancer treatment.

Hangping Yao, Liang Feng, Jianwei Zhou,

PubMed

2016

19

Effects of nanoparticle-mediated Co-delivery of bFGF and VEGFA genes to deep burn wounds: An in vivo study

Qingrong Zhang, Chuwei Zhang, Liang Feng,

Colloids and Surfaces B Biointerfaces

2021

19

Page 1